Spectroscopic study on the mechanism of meloxicam and α-amylase

Xu Cheng, Bao-Sheng Liu, Hongcai Zhang
{"title":"Spectroscopic study on the mechanism of meloxicam and α-amylase","authors":"Xu Cheng, Bao-Sheng Liu, Hongcai Zhang","doi":"10.25082/JPBR.2019.01.004","DOIUrl":null,"url":null,"abstract":"In order to explore the mechanism of action of meloxicam and α-amylase. The interaction between the rheumatoid arthritis drug meloxicam and α-amylase was studied by fluorescence spectroscopy, synchronous fluorescence spectroscopy and molecular docking under the experimental conditions of pH=6.80. The results showed that meloxicam was able to effectively quench the endogenous fluorescence of α-amylase in a static quenching form a 1:1 complex and change the conformation of α-amylase. Thermodynamic results indicated that the main type of meloxicam and α-amylase system was hydrophobic interaction. Molecular docking indicated that the binding system had hydrogen bonds in addition to hydrophobic interaction and meloxicam was surrounded by the active amino acid residues Trp13 and Trp263 of α-amylase, which changed the microenvironment of amino acid residues at the active center of α-amylase. By establishing the binding model, it can be seen that the protein binding rate W(B) of meloxicam to α-amylase was 2.76%-41.79% under the experimental conditions. The results showed that the binding of meloxicam to α-amylase had an effect on the number of free α-amylase. The drug binding rate W(Q) of the system was 2.76%-1.67%, which indicated that the combination of α-amylase and meloxicam would not affect the efficacy of meloxicam.","PeriodicalId":16703,"journal":{"name":"Journal of Pharmaceutical and Biopharmaceutical Research","volume":"16 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical and Biopharmaceutical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25082/JPBR.2019.01.004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

In order to explore the mechanism of action of meloxicam and α-amylase. The interaction between the rheumatoid arthritis drug meloxicam and α-amylase was studied by fluorescence spectroscopy, synchronous fluorescence spectroscopy and molecular docking under the experimental conditions of pH=6.80. The results showed that meloxicam was able to effectively quench the endogenous fluorescence of α-amylase in a static quenching form a 1:1 complex and change the conformation of α-amylase. Thermodynamic results indicated that the main type of meloxicam and α-amylase system was hydrophobic interaction. Molecular docking indicated that the binding system had hydrogen bonds in addition to hydrophobic interaction and meloxicam was surrounded by the active amino acid residues Trp13 and Trp263 of α-amylase, which changed the microenvironment of amino acid residues at the active center of α-amylase. By establishing the binding model, it can be seen that the protein binding rate W(B) of meloxicam to α-amylase was 2.76%-41.79% under the experimental conditions. The results showed that the binding of meloxicam to α-amylase had an effect on the number of free α-amylase. The drug binding rate W(Q) of the system was 2.76%-1.67%, which indicated that the combination of α-amylase and meloxicam would not affect the efficacy of meloxicam.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
美洛昔康与α-淀粉酶作用机理的光谱研究
目的探讨美洛昔康与α-淀粉酶的作用机制。在pH=6.80的实验条件下,采用荧光光谱法、同步荧光光谱法和分子对接法研究类风湿关节炎药物美洛昔康与α-淀粉酶的相互作用。结果表明,美洛昔康能够有效猝灭α-淀粉酶的内源荧光,形成1:1的络合物,改变α-淀粉酶的构象。热力学结果表明,美洛昔康与α-淀粉酶体系以疏水相互作用为主。分子对接表明,该结合体系除疏水相互作用外还存在氢键,并且美洛昔康被α-淀粉酶活性氨基酸残基Trp13和Trp263包围,改变了α-淀粉酶活性中心氨基酸残基的微环境。通过建立结合模型可以看出,在实验条件下,美洛昔康与α-淀粉酶的蛋白结合率W(B)为2.76% ~ 41.79%。结果表明,美洛昔康与α-淀粉酶的结合对游离α-淀粉酶的数量有影响。该体系的药物结合率W(Q)为2.76% ~ 1.67%,说明α-淀粉酶与美洛昔康联用不会影响美洛昔康的疗效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The clinical and regulatory status of NDSRI: A global imperative A big threat : Aflatoxin Determination of pesticide residues and heavy metals in Adhatoda Vasaka Linn. TAAR1 as a new target for the treatment of bipolar disorder: Anti-manic and anti-depressant activity of the novel agonist PCC0105004 A novel role of NK3 receptor signaling in bipolar disorder
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1